Siblings 圖書 [1/1] 會議論文/會議摘要 [10/11] 專利 [0/24] Collection Statistics 近3年內發表的文件:18(15.93%) 含全文筆數:110(97.35%) 文件下載次數統計 下載大於0次:110(100.00%) 下載大於100次:105(95.45%) 檔案下載總次數:62448(92.25%) 最後更新時間: 2024-12-01 13:03 Top Upload Loading... Top Download Loading... Recent Submissions Boosting DNA vaccine power by lipid... ADAM9 drives the immunosuppressive ... Inhibition of ADAM9 promotes the se... Lipid nanoparticle-encapsulated DNA... A broad-spectrum pneumococcal vacci... Co-delivery of a trimeric spike DNA... A TLR9 agonist synergistically enha... TLR9 and STING agonists cooperative... Recombinant lipidated FLIPr effecti... Humoral and cellular immunity in th...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 51-75 of 113. (5 Page(s) Totally) << < 1 2 3 4 5 > >> View [10|25|50] records per page

Date	Title	Relation
2015-10	Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy	OncoImmunology. 2015 Oct 29;5(3):e1095433.
2015-08-07	Recombinant lipoprotein-based vaccine candidates against C. difficile infections	Journal of Biomedical Science. 2015 Aug 7;22:Article number 65.
2015-07-28	A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms	Scientific Reports. 2015 Jul 28;5:Article number 12578.
2015-06	Recombinant lipoproteins as novel vaccines with intrinsic adjuvant	Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74.
2015-03	Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: Potential clinical impact	Expert Review of Vaccines. 2015 Mar;14(3):383-394.
2015-02	漫談預防型和治療型子宮頸癌疫苗的現況與未來	院內感染控制雜誌. 2015 Feb;25(1):31-36.
2014-11	Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide	Human Vaccines and Immunotherapeutics. 2014 Nov;10(11):3241-3250.
2014-08-27	Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice	BioMed Research International. 2014 Aug 27;2014:Article number 878139.
2014-07-30	Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns	Journal of Virology. 2014 Jul 30;88(20):11658-11670.
2014-06-11	Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems	Biomed Research International. 2014 Jun 11;2014:Article number 670506.
2014-05	Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells	Journal of Immunology. 2014 May;192(9):4233-4241.
2014-03-19	Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy	Molecular Cancer. 2014 Mar 19;13:Article number 60.
2014-03	Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity	Vaccine. 2014 Mar;32(12):1346-1353.
2014-03	A purified recombinant lipopeptide as adjuvant for cancer immunotherapy	BioMed Research International. 2014 Mar;2014:Article number 349783.
2014-01	A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity	Journal of Controlled Release. 2014 Jan;173(1):158-165.
2014-01	Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide	Biomaterials. 2014 Jan;35(5):1686-1695.
2013-12	Increased IL-8 and IL-1beta in the bile of acute cholecystitis patients	BioMedicine. 2013 Dec;3(4):181-185.
2013-09-19	Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement	PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432.
2013-09	Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III	Microbes and Infection. 2013 Sep;15(10-11):719-728.
2013-07	A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates	Archives of Virology. 2013 Jul;158(7):1523-1531.
2013-06-13	Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence	ACS Medicinal Chemistry Letters. 2013 Jun 13;4(6):522-526.
2013-05	Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines	Journal of Immunology. 2013 May;190(10):5065-5077.
2012-12	Production of EV71 vaccine candidates	Human Vaccine Immunotherapy. 2012 Dec;8(12):1775-1783.
2012-10	Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapy	Frontiers in Oncology. 2012 Oct;2:Article number 149.
2012-09	Immunological evaluation and comparison of different EV71 vaccine candidates	Clinical and Developmental Immunology. 2012 Sep;2012:Article ID 831282.

Showing items 51-75 of 113. (5 Page(s) Totally) << < 1 2 3 4 5 > >> View [10|25|50] records per page